Inventor · disambiguated record
Mark L. Heiman
Also filed as: HEIMAN MARK L · HEIMAN MARK LOUIS
14 granted patents·8 pending applications·436 citations·filing 1988–2020
93Inventor score
Files withLILLY CO ELI9HEIMAN MARK L4MicroBiome Therapeutics LLC3UNIV TULANE2ELI LILLY AND COMPANY PATENT D1
Top patents by PatentIndex Score
22 records- 0196US4853371ATherapeutic somatostatin analogsUNIV TULANE·Filed 1988·Granted Aug 1, 1989·191 cites·11 claims
- 0294US9040101B2Method to treat diabetes utilizing a gastrointestinal microbiome modulating compositionMicroBiome Therapeutics LLC·Filed 2015·Granted May 26, 2015·39 cites·30 claims
- 0392US4904642ATherapeutic somatostatin analogsUNIV TULANE·Filed 1989·Granted Feb 27, 1990·96 cites·11 claims
- 0490US9463169B2Human gastrointestinal microbiome modulating food supplement for improving blood glucose regulationHEIMAN MARK L·Filed 2012·Granted Oct 11, 2016·23 cites·14 claims
- 0585US10441602B2Human gastrointestinal microbiome modulating composition and methods of useMicroBiome Therapeutics LLC·Filed 2016·Granted Oct 15, 2019·5 cites·19 claims
- 0681US6638936B1Benzofurylpiperazine serotonin agonistsLILLY CO ELI·Filed 2000·Granted Oct 28, 2003·15 cites·18 claims
- 0781US6639076B1Growth hormone secretagoguesLILLY CO ELI·Filed 1999·Granted Oct 28, 2003·25 cites·19 claims
- 0871US11213543B2Human gastrointestinal microbiome modulating composition and methods of useTHE NATURES BOUNTY CO·Filed 2019·Granted Jan 4, 2022·0 cites·22 claims
- 0962US5939387AMethod of treating insulin resistanceLILLY CO ELI·Filed 1996·Granted Aug 17, 1999·20 cites·22 claims
- 1059US6992097B2Growth hormone secretagoguesLILLY CO ELI·Filed 2003·Granted Jan 31, 2006·1 cites·15 claims
- 1151US2006233788A1Anti-ghrelin antibodiesHEIMAN MARK L·Filed 2004·Application pending·0 cites
- 1251US2006269550A1Anti-ghrelin fab antibodiesHEIMAN MARK L·Filed 2004·Application pending·0 cites
- 1348US5965521APulsatile delivery of leptin receptor ligandsLILLY CO ELI·Filed 1997·Granted Oct 12, 1999·10 cites·2 claims
- 1446US2007105759A1Melanocortin receptor 4 (mc4) agonists and their usesLILLY CO ELI·Filed 2004·Application pending·0 cites
- 1545US2006293223A1Uses of melanocortin-3 receptor (mc3r) agonist peptidesELI LILLY AND COMPANY PATENT D·Filed 2004·Application pending·0 cites
- 1644US2022153803A1Modified glucagon molecues and formulations with oxidation resistance and methods and kits of employing the samePURDUE RESEARCH FOUNDATION·Filed 2020·Application pending·0 cites
- 1743US2007123453A1Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusionHEIMAN MARK L·Filed 2004·Application pending·0 cites
- 1843US2014275233A1Activated soy pod fiberMicroBiome Therapeutics LLC·Filed 2014·Application pending·0 cites
- 1941US6323178B1Beta-lipotropin methodsLILLY CO ELI·Filed 1998·Granted Nov 27, 2001·3 cites·19 claims
- 2041US5972888AMethods of treating nueropeptide Y-associated conditionsLILLY CO ELI·Filed 1997·Granted Oct 26, 1999·7 cites·6 claims
- 2134US6221838B1Methods of treating neuropeptide Y-associated conditionsLILLY CO ELI·Filed 1996·Granted Apr 24, 2001·1 cites·16 claims
- 2232US2017065554A1Activated soy pod fiberMicroBlome Therapeutics LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark L. Heiman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →